Literature DB >> 20127026

Characterization of a stem-like population in hepatocellular carcinoma MHCC97 cells.

Ning Zhang1, Ren Li, Kai-Shan Tao, Da-Yong Cao, Zhen-Yu Ti, Rui Ding, Lei Cai, Fu-Qin Zhang, Ke-Feng Dou.   

Abstract

A small stem-like subpopulation was isolated from human hepatocellular carcinoma (HCC) MHCC97 cells, characterized by their high efflux ability of the Hoechst 33342 dye. These side population (SP) cells were able to generate a heterogeneous mixture of SP and main population (MP) cells, while the MP cells rarely generated SP cells. Cell cycle analysis also revealed that more SP cells were in the G0 phase. They express higher levels of BCRP1, AFP and CK19 than MP cells. SP cells showed significantly higher viability than MP cells following treatment with doxorubicin or methotrexate. Actin polymerization and migration assays indicate that SP cells have a higher migration capacity and in vivo tumorigenicity of these cells is also higher. Collectively, we conclude that the SP is an enriched source of stem-like cells and may be an effective target for therapy and a useful tool to investigate the HCC tumorigenic and metastatic process.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20127026

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  12 in total

Review 1.  Cancer stem cells and chemoresistance: The smartest survives the raid.

Authors:  Jihe Zhao
Journal:  Pharmacol Ther       Date:  2016-02-17       Impact factor: 12.310

Review 2.  Deconstructing the mechanisms and consequences of TGF-β-induced EMT during cancer progression.

Authors:  Michael K Wendt; Maozhen Tian; William P Schiemann
Journal:  Cell Tissue Res       Date:  2011-06-21       Impact factor: 5.249

3.  Overexpression of miR-200a suppresses epithelial-mesenchymal transition of liver cancer stem cells.

Authors:  Jianlin Wang; Xisheng Yang; Bai Ruan; Bin Dai; Yuan Gao; Juanli Duan; Shibin Qu; Kaishan Tao; Kefeng Dou; Haimin Li
Journal:  Tumour Biol       Date:  2014-11-22

Review 4.  Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance.

Authors:  Zhiwei Wang; Yiwei Li; Aamir Ahmad; Asfar S Azmi; Dejuan Kong; Sanjeev Banerjee; Fazlul H Sarkar
Journal:  Drug Resist Updat       Date:  2010-08-09       Impact factor: 18.500

5.  Sorting and biological characteristics analysis for side population cells in human primary hepatocellular carcinoma.

Authors:  Yegui Jiang; Hucheng Gao; Mingdong Liu; Qing Mao
Journal:  Am J Cancer Res       Date:  2016-09-01       Impact factor: 6.166

6.  Antigen-specific T cell response from dendritic cell vaccination using side population cell-associated antigens targets hepatocellular carcinoma.

Authors:  Xiao Li; Zhuochao Zhang; Guoying Lin; Yuanxing Gao; Zhen Yan; Heliang Yin; Bingyi Sun; Fangyuan Wang; Haijun Zhang; Hong Chen; Dayong Cao
Journal:  Tumour Biol       Date:  2016-03-07

7.  GNAQ knockdown promotes bone metastasis through epithelial-mesenchymal transition in lung cancer cells.

Authors:  Ji-Yoon Choi; Yun Sun Lee; Da Mi Shim; Young Keun Lee; Sung Wook Seo
Journal:  Bone Joint Res       Date:  2021-05       Impact factor: 5.853

Review 8.  New Insights into the Crossroads between EMT and Stemness in the Context of Cancer.

Authors:  Isabel Fabregat; Andrea Malfettone; Jitka Soukupova
Journal:  J Clin Med       Date:  2016-03-12       Impact factor: 4.241

9.  Downregulation of miR-200a induces EMT phenotypes and CSC-like signatures through targeting the β-catenin pathway in hepatic oval cells.

Authors:  Jie Liu; Bai Ruan; Nan You; Qike Huang; Weihui Liu; Zheng Dang; Weihua Xu; Ti Zhou; Ru Ji; Yang Cao; Xia Li; Desheng Wang; Kaishan Tao; Kefeng Dou
Journal:  PLoS One       Date:  2013-11-15       Impact factor: 3.240

10.  Continuous exposure of pancreatic cancer cells to dietary bioactive agents does not induce drug resistance unlike chemotherapy.

Authors:  P Fan; Y Zhang; L Liu; Z Zhao; Y Yin; X Xiao; N Bauer; J Gladkich; J Mattern; C Gao; P Schemmer; W Gross; I Herr
Journal:  Cell Death Dis       Date:  2016-06-02       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.